Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study
Ronald Emkey, Pierre D. Delmas, Michael Bolognese, Joao Lindolfo C. Borges, Felicia Cosman, Sergio Ragi-Eis, Christopher Recknor, Cristiano A. Zerbini, Colin Neate, Farhad Sedarati, Solomon EpsteinVolume:
31
Year:
2009
Language:
english
Pages:
11
DOI:
10.1016/j.clinthera.2009.04.018
File:
PDF, 145 KB
english, 2009